Ligand validation:9D6Z

MTX: METHOTREXATE

MTX is a Ligand Of Interest in 9D6Z designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9D6Z_MTX_B_409	91%	60%	0.062	0.949	0.73	0.8	1	-	4	0	100%	1
9D6Z_MTX_A_408	43%	58%	0.121	0.843	0.8	0.81	2	2	4	0	100%	1
9D6X_MTX_D_401	100%	64%	0.041	0.984	0.7	0.67	1	-	2	0	100%	1
9D71_MTX_B_401	53%	66%	0.107	0.868	0.66	0.66	1	-	4	0	100%	1
1RB3_MTX_B_161	98%	6%	0.049	0.969	2	3.05	11	22	5	0	100%	1
1RA3_MTX_A_161	97%	9%	0.058	0.974	1.61	2.84	8	23	3	0	100%	1
1U72_MTX_A_188	97%	20%	0.065	0.979	1.13	2.23	2	16	4	0	100%	1
1RG7_MTX_A_161	94%	7%	0.071	0.968	1.88	2.93	9	17	3	0	100%	1
1DDR_MTX_B_200	93%	2%	0.077	0.971	2.29	4.49	7	20	0	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.